Get started
Author

Caroline E. Johnson

Observed name: Caroline Johnson
OpenAlex ID: A5004249345
Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S
2025 · Sandra Smieszek, Bartlomiej Przychodzen, et al. · Molecular Therapy — Nucleic Acids · 8
Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis
2026 · Sandra Smieszek, Bartlomiej Przychodzen, et al. · NEJM Evidence · 4
0879 Dim Light Melatonin Onset in a Delayed Sleep-Wake Phase Disorder Cohort: Ongoing Clinical Trial Update
2025 · Caroline Johnson, Jennifer Brzezynski, et al. · SLEEP · 1
PDF
Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study
2023 · Sandra P. Smieszek, Alyssa R. Kaden, et al. · Frontiers in Neuroscience · 1
Translating IGHMBP2 Variants with a CMT2S Patient-specific Organ-on-a-chip Model: Personalized Medicine ASO-based Therapeutic Rescue (P12-11.017)
2025 · Sandra Smieszek, Bart Przychodzen, et al. · Neurology
0678 Genetic Variants Associated with Dim Light Melatonin Onset in a Delayed Sleep-Wake Phase Disorder Cohort
2024 · Jennifer Brzezynski, Caroline Johnson, et al. · SLEEP
Translating the Effects of CMT2S Variants with Human-on-a-chip Neuromuscular Junction Systems (P2-11.014)
2024 · Caroline Johnson, Sandra Smieszek, et al. · Neurology
Potential ASO-based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S (S5.009)
2024 · Christina Tyner, Sandra Smieszek, et al. · Neurology
Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study
2024 · Sandra P. Smieszek, Alyssa R. Kaden, et al. · Frontiers in Neuroscience
PDF
Works count: 9
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type